Monthly Archives: November 2016

18 November 2016

Exonate – University of Bristol Enterprise Fund I investment

By |November 18th, 2016|

We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, has invested in Exonate.

Exonate are developing a novel approach to modulating new vessel growth.  By controlling the balance of two contrasting forms of a protein called Vascular Endothelial Growth Factor (VEGF), they have demonstrated that they could not only treat models […]

Cambridge Touch Technologies – follow-on investment

By |November 9th, 2016|

We have recently made a follow-on investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund IV, the Parkwalk UK Tech Fund VII and the Parkwalk Opportunities Fund  in a series ‘A’ financing round.

Cambridge Touch Technologies (CTT), a University of Cambridge start-up poised to make 3D touch technology a standard feature on smart […]

Parkwalk closes Mirriad follow-on investment

By |November 3rd, 2016|

We are pleased to announce that Parkwalk have closed a follow-on investment into Mirriad, the leading provider of NIVA (Native In-Video Advertising) services to brands and agencies looking to address the growing challenges presented by ad skipping and ad blindness. The Mirriad technology was originally developed at Surrey University,

Mirriad claims to have the most integrated set […]